Jacobs Levy Equity Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,195
| Closed | -$83K | – | 1065 |
|
|
2021
Q1 | $83K | Sell |
2,195
-5,869
| -73% | -$222K | ﹤0.01% | 997 |
|
|
2020
Q4 | $382K | Sell |
8,064
-8,586
| -52% | -$407K | ﹤0.01% | 885 |
|
|
2020
Q3 | $537K | Buy |
16,650
+2,927
| +21% | +$94.4K | 0.01% | 776 |
|
|
2020
Q2 | $604K | Buy |
+13,723
| New | +$604K | 0.01% | 759 |
|
|
2014
Q2 | – | Sell |
-41
| Closed | -$152K | – | 864 |
|
|
2014
Q1 | $152K | Hold |
41
| – | – | ﹤0.01% | 839 |
|
|
2013
Q4 | $135K | Sell |
41
-49
| -54% | -$161K | ﹤0.01% | 895 |
|
|
2013
Q3 | $376K | Sell |
90
-85
| -49% | -$355K | 0.01% | 752 |
|
|
2013
Q2 | $587K | Buy |
+175
| New | +$587K | 0.01% | 693 |
|